| Hans-Günter Meyer-Thompson | international
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.
Leveraging COVID-19 to sustain regulatory flexibility in the treatment of opioid use disorder.
Stringer KL, Langdon KJ, McKenzie M, Brockmann B, Marotta P.
J Subst Abuse Treat. 2021 Apr;123:108263. doi: 10.1016/j.jsat.2020.108263. Epub 2020 Dec 26. PMID: 33612196; PMCID: PMC7900610.
Abstract
https://www.journalofsubstanceabusetreatment.com/artichttps://www.journalofsubstanceabusetreatment.com/article/S0740-5472(20)30520-1/fulltext